glp 1 agonists for alcohol use disorder Searching New Pharmacological Treatments of (AUD): Focus on GLP–1 Receptor GLP-1 receptor agonists show promise

Yazbeck R, Abbott CA, Howarth GS (2010a) The use of GLP-2 and related growth factors in intestinal diseases

We identified eighty six rodent and ten human studies investigating a nutritional intervention to ameliorate ES-induced impairments

Halliwell B, Gutteridge JM

T2DM: type 2 diabetes mellitus Recent research has revealed that TMAO may be a risk factor for the onset and progression of atherosclerosis, along with food and gut microbiota both of which may play a role in the development of cardiovascular disease, including atherosclerosis [68, 69]

The fix: always submit D63.1 with N18.1 through N18.6 sequenced first, per ICD-10-CM sequencing requirements